This has served as a platform for completed and ongoing clinical studies in osteogenesis imperfecta, hypophosphatasia, x-linked hypophosphatemic rickets, and steroid-induced osteoporosis.

Since her fellowship, Dr. DiMeglio has been working in clinical research with a focus on Type 1 diabetes prevention and treatments, including new technologies, and also in the area of therapies for metabolic bone disease.

Dr. DiMeglio directs Riley Hospital’s participation in several type 1 diabetes research networks and supervises a research staff includng nurses, research coordinators, and technicians.

My areas of interest in my clinical practice include metabolic bone and calcium disorders and type 1 diabetes treatment and prevention.

Subject area:

  • Pediatric Musculoskeletal Disease

Research: Islet Function and Survival

Endocrinology, Pediatrics, Pediatrics
MPH, Indiana University, 2006
MD, University of Pennsylvania, 1993
AB, Harvard University, Biology, 1989
MA, Harvard University, Biology, 1989
diabetes endocrinologic diseases osteogenesis imperfecta osteoporosis & other bone diseases hormones & endocrinology pediatrics
American Diabetes Association
International Society for Pediatric and Adolescent Diabetes
Pediatric Endocrine Society
American Society for Bone and Mineral Research
American Academy of Pediatrics
Endocrine Society